Insmed Inc (INSM)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

$93.75

Buy

$95.15

arrow-down$-10.70 (-10.20%)

Prices updated at 06 Jun 2026, 00:50 EDT

Prices minimum 15 mins delay

Prices in USD

Insmed Inc is a biopharmaceutical company. Its commercial portfolio and clinical pipeline are organized around three therapeutic areas: Respiratory, Immunology and Inflammation, and Neuro and Other Rare. The company's two commercial products, Arikayce ...

NASDAQ

-4.18%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

our Investment Fees and Charges.

	$105.00 - $92.81
	$212.75 - $70.57
	-
	20,422.42m
	-
	-
	7,956,670
	28.97
	3,058,777.83
	1.10
	214.26m
	US4576693075
	-5.76
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.